bluebird bio Inc (BLUE)
0.3821
-0.06
(-13.04%)
USD |
NASDAQ |
Nov 07, 16:00
0.3695
-0.01
(-3.30%)
After-Hours: 06:29
bluebird bio Revenue (Annual): 29.50M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 29.50M |
| December 31, 2022 | 3.597M |
| December 31, 2021 | 3.662M |
| December 31, 2020 | |
| December 31, 2019 | |
| December 31, 2018 | 54.58M |
| December 31, 2017 | 35.43M |
| Date | Value |
|---|---|
| December 31, 2016 | 6.155M |
| December 31, 2015 | 14.08M |
| December 31, 2014 | 25.42M |
| December 31, 2013 | 20.18M |
| December 31, 2012 | 0.34M |
| December 31, 2011 | 0.882M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
3.597M
Minimum
2022
29.50M
Maximum
2023
12.25M
Average
3.662M
Median
2021
Revenue (Annual) Benchmarks
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 65.49M |
| Predictive Oncology Inc | 1.780M |
| Spectral AI Inc | 18.06M |
| Vertex Pharmaceuticals Inc | 9.869B |